12:00 AM
Aug 07, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Results

DP-b99: Phase I

In a placebo-controlled Phase I trial in 24 healthy male volunteers in Germany, intravenous escalating doses of 3-1000 ug/kg of DP-b99 were well tolerated,...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >